Dr Gevorg Tamamyan is Nominated as a Candidate for WHO Director-General Position
Immuno 2026 Day 3 Highlights: Cancer Vaccines, Local Immunotherapy and the Patient Perspective
KEYNOTE-671: Perioperative Pembrolizumab Redefines Curative-Intent Therapy in Resectable NSCLC
Victor Moreno: Bringing Lirafugratinib From a First-In-Human Trial to an FDA-Approved Treatment
Daiichi Sankyo and Merck Withdraw Ifinatamab Deruxtecan BLA for Previously Treated Extensive-Stage SCLC
Highlights from World Cancer Congress 2026
IMpassion050 Final Results: Atezolizumab Does Not Improve Long-Term Outcomes in High-Risk HER2-Positive Early Breast Cancer
Gustavo Fonseca at COGC 2026: Making Community Clinical Trials Truly Work
